These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17611583)

  • 1. Critical assessment of lifelong phenotype correction in hyperbilirubinemic Gunn rats after retroviral mediated gene transfer.
    Nguyen TH; Aubert D; Bellodi-Privato M; Flageul M; Pichard V; Jaidane-Abdelghani Z; Myara A; Ferry N
    Gene Ther; 2007 Sep; 14(17):1270-7. PubMed ID: 17611583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful gene therapy of the Gunn rat by in vivo neonatal hepatic gene transfer using murine oncoretroviral vectors.
    Bellodi-Privato M; Aubert D; Pichard V; Myara A; Trivin F; Ferry N
    Hepatology; 2005 Aug; 42(2):431-8. PubMed ID: 16025517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune response to lentiviral bilirubin UDP-glucuronosyltransferase gene transfer in fetal and neonatal rats.
    Seppen J; van Til NP; van der Rijt R; Hiralall JK; Kunne C; Elferink RP
    Gene Ther; 2006 Apr; 13(8):672-7. PubMed ID: 16267566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic lentivirus-mediated neonatal in vivo gene therapy in hyperbilirubinemic Gunn rats.
    Nguyen TH; Bellodi-Privato M; Aubert D; Pichard V; Myara A; Trono D; Ferry N
    Mol Ther; 2005 Nov; 12(5):852-9. PubMed ID: 16140582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentiviral vectors that express UGT1A1 in liver and contain miR-142 target sequences normalize hyperbilirubinemia in Gunn rats.
    Schmitt F; Remy S; Dariel A; Flageul M; Pichard V; Boni S; Usal C; Myara A; Laplanche S; Anegon I; Labrune P; Podevin G; Ferry N; Nguyen TH
    Gastroenterology; 2010 Sep; 139(3):999-1007, 1007.e1-2. PubMed ID: 20546738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy with bilirubin-UDP-glucuronosyltransferase in the Gunn rat model of Crigler-Najjar syndrome type 1.
    Li Q; Murphree SS; Willer SS; Bolli R; French BA
    Hum Gene Ther; 1998 Mar; 9(4):497-505. PubMed ID: 9525311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of UGT1A1 deficiency in a rat model of Crigler-Najjar disease by intravenous administration of a liver-specific lentiviral vector.
    van der Wegen P; Louwen R; Imam AM; Buijs-Offerman RM; Sinaasappel M; Grosveld F; Scholte BJ
    Mol Ther; 2006 Feb; 13(2):374-81. PubMed ID: 16337205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrovirus-mediated expression of HUG Br1 in Crigler-Najjar syndrome type I human fibroblasts and correction of the genetic defect in Gunn rat hepatocytes.
    Askari F; Hitomi E; Thiney M; Wilson JM
    Gene Ther; 1995 May; 2(3):203-8. PubMed ID: 7614251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transplantation of Gunn rats with autologous fibroblasts expressing bilirubin UDP-glucuronosyltransferase: correction of genetic deficiency and tumor formation.
    Seppen J; Tada K; Ottenhoff R; Sengupta K; Chowdhury NR; Chowdhury JR; Bosma PJ; Oude Elferink RP
    Hum Gene Ther; 1997 Jan; 8(1):27-36. PubMed ID: 8989992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adeno-associated virus vector serotypes mediate sustained correction of bilirubin UDP glucuronosyltransferase deficiency in rats.
    Seppen J; Bakker C; de Jong B; Kunne C; van den Oever K; Vandenberghe K; de Waart R; Twisk J; Bosma P
    Mol Ther; 2006 Jun; 13(6):1085-92. PubMed ID: 16581301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler-Najjar syndrome type I following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferase.
    Askari FK; Hitomi Y; Mao M; Wilson JM
    Gene Ther; 1996 May; 3(5):381-8. PubMed ID: 9156798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durable correction of inherited metabolic liver disorders requires preventing transgene off-targeting from gene therapy vectors: the value of microRNAs.
    Gonzalez-Aseguinolaza G; Prieto J
    Gastroenterology; 2010 Sep; 139(3):726-9. PubMed ID: 20655958
    [No Abstract]   [Full Text] [Related]  

  • 13. Ex vivo lentivirus transduction and immediate transplantation of uncultured hepatocytes for treating hyperbilirubinemic Gunn rat.
    Nguyen TH; Birraux J; Wildhaber B; Myara A; Trivin F; Le Coultre C; Trono D; Chardot C
    Transplantation; 2006 Sep; 82(6):794-803. PubMed ID: 17006327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridine-diphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler-Najjar syndrome.
    Thummala NR; Ghosh SS; Lee SW; Reddy B; Davidson A; Horwitz MS; Chowdhury JR; Chowdhury NR
    Gene Ther; 2002 Aug; 9(15):981-90. PubMed ID: 12101428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AAV8 Gene Therapy Rescues the Newborn Phenotype of a Mouse Model of Crigler-Najjar.
    Greig JA; Nordin JML; Draper C; Bell P; Wilson JM
    Hum Gene Ther; 2018 Jul; 29(7):763-770. PubMed ID: 29448836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single hepatic venous injection of liver-specific naked plasmid vector expressing human UGT1A1 leads to long-term correction of hyperbilirubinemia and prevention of chronic bilirubin toxicity in Gunn rats.
    Jia Z; Dankó I
    Hum Gene Ther; 2005 Aug; 16(8):985-95. PubMed ID: 16076256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonviral gene transfer into liver and muscle for treatment of hyperbilirubinemia in the gunn rat.
    Dankó I; Jia Z; Zhang G
    Hum Gene Ther; 2004 Dec; 15(12):1279-86. PubMed ID: 15684703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezetimibe: A biomarker for efficacy of liver directed UGT1A1 gene therapy for inherited hyperbilirubinemia.
    Montenegro-Miranda PS; Sneitz N; de Waart DR; Ten Bloemendaal L; Duijst S; de Knegt RJ; Beuers U; Finel M; Bosma PJ
    Biochim Biophys Acta; 2012 Aug; 1822(8):1223-9. PubMed ID: 22546842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient increase in intrahepatic pressure mediates successful treatment of the Gunn rat with reduced doses of lentiviral vector.
    Schmitt F; Flageul M; Dariel A; Pichard V; Pontes CA; Boni S; Podevin G; Myara A; Ferry N; Nguyen TH
    Hum Gene Ther; 2010 Oct; 21(10):1349-56. PubMed ID: 20486774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of hyperbilirubinemia in gunn rats using clinically relevant low doses of helper-dependent adenoviral vectors.
    Dimmock D; Brunetti-Pierri N; Palmer DJ; Beaudet AL; Ng P
    Hum Gene Ther; 2011 Apr; 22(4):483-8. PubMed ID: 20973621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.